Fig. 2From: Efficacy and safety of IL-17 inhibitors for the treatment of ankylosing spondylitis: a systematic review and meta-analysisForest plot of the efficacy of IL-17 inhibitors in the treatment of patients with ankylosing spondylitis, using ASAS20 (a) and ASAS40 (b). ASAS20/40, Assessment of Spondyloarthritis International Society response criteria for improvement of 20%/40%; RR, risk ratioBack to article page